PubRank

R J Daly

Author PubWeight™ 56.97‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 1992 8.20
2 SH2 domains prevent tyrosine dephosphorylation of the EGF receptor: identification of Tyr992 as the high-affinity binding site for SH2 domains of phospholipase C gamma. EMBO J 1992 2.82
3 Mood and behavioural changes with progestational agents. Br J Psychiatry 1967 1.72
4 The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules. Br J Haematol 1996 1.64
5 Exposure of Gambian children to Anopheles gambiae malaria vectors in an irrigated rice production area. Med Vet Entomol 1995 1.62
6 Coal gas and the brain. Br Med J 1968 1.52
7 Increased soluble interleukin 2 receptor levels in schizophrenia. Schizophr Res 1998 1.45
8 Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2. Oncogene 1994 1.44
9 Ability of Anopheles gambiae mosquitoes to transmit malaria during the dry and wet seasons in an area of irrigated rice cultivation in The Gambia. J Trop Med Hyg 1991 1.39
10 Signaling pathways and structural domains required for phosphorylation of EMS1/cortactin. Cancer Res 1999 1.39
11 Identification of a novel human tankyrase through its interaction with the adaptor protein Grb14. J Biol Chem 2001 1.38
12 Psychosis associated with the use of a sequential oral contraceptive. Lancet 1967 1.31
13 Analysis of Grb7 recruitment by heregulin-activated erbB receptors reveals a novel target selectivity for erbB3. J Biol Chem 1998 1.21
14 Functional analysis of the regulatory requirements of B-Raf and the B-Raf(V600E) oncoprotein. Oncogene 2006 1.18
15 Structural determinants of the interaction between the erbB2 receptor and the Src homology 2 domain of Grb7. J Biol Chem 1997 1.08
16 EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer. Oncogene 1997 1.08
17 The ras signaling pathway in mammary tumorigenesis and metastasis. J Mammary Gland Biol Neoplasia 2001 1.07
18 Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitors. Leukemia 2012 1.06
19 EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival. Oncogene 1998 1.05
20 Interpersonal problem-solving skills training in the treatment of self-poisoning patients. Suicide Life Threat Behav 1994 1.05
21 Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells. Oncogene 1998 1.04
22 Effects of oestrogen on the expression of a 4.4 kb mRNA in the ZR-75-1 human breast cancer cell line. Mol Cell Endocrinol 1988 1.02
23 Annexin A6 inhibits Ras signalling in breast cancer cells. Oncogene 2008 1.00
24 Gab2 and Src co-operate in human mammary epithelial cells to promote growth factor independence and disruption of acinar morphogenesis. Oncogene 2007 0.99
25 Up-regulation of the protein tyrosine phosphatase SHP-1 in human breast cancer and correlation with GRB2 expression. Int J Cancer 2000 0.98
26 Functional characterization of cancer-associated Gab1 mutations. Oncogene 2012 0.97
27 The human GRB2 and Drosophila Drk genes can functionally replace the Caenorhabditis elegans cell signaling gene sem-5. Mol Biol Cell 1993 0.96
28 The effects of L-methionine (without MAOI) in schizophrenia. J Psychiatr Res 1971 0.96
29 Annexin A6 is a scaffold for PKCα to promote EGFR inactivation. Oncogene 2012 0.93
30 Hostility and chronic intermittent haemodialysis. J Psychosom Res 1969 0.89
31 Flying phobia: phobia: phenomenological study. Proc R Soc Med 1970 0.88
32 Expression and tyrosine phosphorylation of EMS1 in human breast cancer cell lines. Int J Cancer 1996 0.86
33 Approaches to studying the role of growth factors in the progression of breast tumours from the steroid sensitive to insensitive state. J Steroid Biochem 1989 0.85
34 The antiproliferative effects of progestins in T47D breast cancer cells are tempered by progestin induction of the ETS transcription factor Elf5. Mol Endocrinol 2010 0.83
35 Granulosa cell tumors express erbB4 and are sensitive to the cytotoxic action of heregulin-beta2/PE40. Cancer Res 1998 0.83
36 Mianserin in the treatment of depressive illness: a comparison with amitriptyline. Ir J Med Sci 1979 0.82
37 Interpersonal problem-solving deficits in self-poisoning patients. Suicide Life Threat Behav 1987 0.80
38 Heregulin (HRG)-induced mitogenic signaling and cytotoxic activity of a HRG/PE40 ligand toxin in human breast cancer cells. Cell Growth Differ 1995 0.78
39 Tyrosine kinase signalling in breast cancer: modulation of tyrosine kinase signalling in human breast cancer through altered expression of signalling intermediates. Breast Cancer Res 2000 0.78
40 Two severe reactions to benzodiazepine compounds. Am J Psychiatry 1965 0.77
41 Transition of human breast cancer cells from an oestrogen responsive to unresponsive state. J Steroid Biochem Mol Biol 1990 0.76
42 Liaison psychiatry in an Irish hospital: a survey of a year's experience. Gen Hosp Psychiatry 1986 0.76
43 Assignment of the human GRB14 gene to chromosome 2q22-q24 by fluorescence in situ hybridization. Genomics 1996 0.76
44 Reported sleep on maintenance haemodialysis. Br Med J 1970 0.76
45 Samuel Pepys and post-traumatic stress disorder. Br J Psychiatry 1983 0.76
46 Treatment of flying phobia in trained aircrew. Proc R Soc Med 1970 0.75
47 Treatment of flying phobia in aircrew. Am J Psychother 1971 0.75
48 Amelioration of premenstrual mood disturbance with a progestational agent (enovid). Dis Nerv Syst 1966 0.75
49 Compensation and rehabilitation of victims of torture. An example of preventive psychiatry. Dan Med Bull 1980 0.75
50 Stress in medical students. Ir Med J 1997 0.75
51 Koro-like syndrome associated with brief reactive psychosis in an Irish male. Ir Med J 1996 0.75
52 The after-hours psychiatric emergency. Health Bull (Edinb) 1970 0.75
53 Urine volume and pink spots in schizophrenia and health. Nature 1969 0.75
54 Panic disorder. Ir Med J 1993 0.75
55 Endocrine profiles in premenstrual tension. Clin Endocrinol (Oxf) 1972 0.75
56 Some observations concerning the "pink spot" reacting substances in urine. Acta Psychiatr Scand 1970 0.75
57 Affect ive disorder taxonomies in middle-aged females. Br J Psychiatry 1968 0.75
58 Soluble interleukin 2 receptor levels in acute and stable schizophrenia. Schizophr Res 2001 0.75